247 related articles for article (PubMed ID: 19721392)
1. Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects.
Cable DG; Celotto AC; Evora PR; Schaff HV
Med Sci Monit; 2009 Sep; 15(9):BR248-53. PubMed ID: 19721392
[TBL] [Abstract][Full Text] [Related]
2. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
Segarra G; Cortina B; Mauricio MD; Novella S; Lluch P; Navarrete-Navarro J; Noguera I; Medina P
World J Gastroenterol; 2016 Dec; 22(48):10545-10556. PubMed ID: 28082806
[TBL] [Abstract][Full Text] [Related]
3. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
Jiang JL; Li Ns NS; Li YJ; Deng HW
Br J Pharmacol; 2002 Mar; 135(5):1175-82. PubMed ID: 11877324
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor.
Böger RH
J Nutr; 2004 Oct; 134(10 Suppl):2842S-2847S; discussion 2853S. PubMed ID: 15465797
[TBL] [Abstract][Full Text] [Related]
5. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure.
Feng Q; Lu X; Fortin AJ; Pettersson A; Hedner T; Kline RL; Arnold JM
Cardiovasc Res; 1998 Mar; 37(3):667-75. PubMed ID: 9659450
[TBL] [Abstract][Full Text] [Related]
6. The ability of asymmetric dimethylarginine (ADMA) or monomethylarginine (L-NMMA) to block endothelium-dependent, nitric oxide-mediated relaxation in rat aorta is inversely related to the efficacy of the relaxant stimulus.
Al-Zobaidy MJ; Martin W
Eur J Pharmacol; 2014 Oct; 741():171-7. PubMed ID: 25149663
[TBL] [Abstract][Full Text] [Related]
7. Role of endothelium and nitric oxide in histamine-induced responses in human cranial arteries and detection of mRNA encoding H1- and H2-receptors by RT-PCR.
Jansen-Olesen I; Ottosson A; Cantera L; Strunk S; Lassen LH; Olesen J; Mortensen A; Engel U; Edvinsson L
Br J Pharmacol; 1997 May; 121(1):41-8. PubMed ID: 9146885
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
[TBL] [Abstract][Full Text] [Related]
9. Association of asymmetric dimethylarginine and endothelial dysfunction.
Böger RH
Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice.
Chataigneau T; Félétou M; Huang PL; Fishman MC; Duhault J; Vanhoutte PM
Br J Pharmacol; 1999 Jan; 126(1):219-26. PubMed ID: 10051139
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-dependent relaxation by substance P in human isolated omental arteries and veins: relative contribution of prostanoids, nitric oxide and hyperpolarization.
Wallerstedt SM; Bodelsson M
Br J Pharmacol; 1997 Jan; 120(1):25-30. PubMed ID: 9117094
[TBL] [Abstract][Full Text] [Related]
12. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
[TBL] [Abstract][Full Text] [Related]
13. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
[TBL] [Abstract][Full Text] [Related]
14. Contribution of K+ channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries.
Prieto D; Simonsen U; Hernández M; García-Sacristán A
Br J Pharmacol; 1998 Apr; 123(8):1609-20. PubMed ID: 9605568
[TBL] [Abstract][Full Text] [Related]
15. Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor.
Jin JS; D'Alecy LG
J Cardiovasc Pharmacol; 1996 Sep; 28(3):439-46. PubMed ID: 8877592
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
Toutouzas K; Riga M; Stefanadi E; Stefanadis C
Horm Metab Res; 2008 Sep; 40(9):655-9. PubMed ID: 18792879
[TBL] [Abstract][Full Text] [Related]
17. Involvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired neurogenic relaxation of the rabbit proximal urethra with ischaemia.
Masuda H; Tsujii T; Okuno T; Kihara K; Goto M; Azuma H
Br J Pharmacol; 2001 May; 133(1):97-106. PubMed ID: 11325799
[TBL] [Abstract][Full Text] [Related]
18. Enhanced prostanoid-mediated vasorelaxation in pulmonary arteries isolated during experimental endotoxemia.
Myers TP; Myers PR; Adams HR; Parker JL
Shock; 1999 Jun; 11(6):436-42. PubMed ID: 10454834
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in endothelium-dependent relaxation in the rat: contribution of nitric oxide and nitric oxide-independent mechanisms.
Zygmunt PM; Ryman T; Högestätt ED
Acta Physiol Scand; 1995 Nov; 155(3):257-66. PubMed ID: 8619323
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
Maas R
Vasc Med; 2005 Jul; 10 Suppl 1():S49-57. PubMed ID: 16444869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
